Advancing Clinical Trial Participation for the LGBTQIA+ Community

https://www.fda.gov/news-events/fda-voices/advancing-clinical-trial-participation-lgbtqia-community?utm_medium=email&utm_source=govdelivery In late June, representatives of the U.S. Food and Drug Administration were fortunate to attend a community discussion on advancing clinical trial diversity for sexual and gender minority communities to help improve the generalizability of trial results across the entire population of patients who may use medical products. In collaboration with the North Carolina Community Health Center Association and the Association of Clinical Research Professionals-Research Triangle Park Chapter in North Carolina, the roundtable included members of the REACH Consortium, researchers, patients, community members, and LGBTQIA+ health professionals and advocates.